Thyroid Eye Disease Overview

Save information for later
Sign Up

Learn About Thyroid Eye Disease

Condition 101 content is not available at this time, but we are continually updating the site. Please check back.

However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.

Who are the top Thyroid Eye Disease Local Doctors?
Elite in Thyroid Eye Disease
Elite in Thyroid Eye Disease
653 N Town Ctr Dr, Suite 512, 
Las Vegas, NV 
Languages Spoken:
English
Accepting New Patients

Raymond Douglas is an Ophthalmologist in Las Vegas, Nevada. Dr. Douglas is rated as an Elite provider by MediFind in the treatment of Thyroid Eye Disease. His top areas of expertise are Thyroid Eye Disease, Graves Disease, Eyelid Drooping, and Ptosis. Dr. Douglas is currently accepting new patients.

Elite in Thyroid Eye Disease
Ophthalmology
Elite in Thyroid Eye Disease
Ophthalmology
178 E 71st St, 
New York, NY 
Languages Spoken:
English

Michael Kazim is an Ophthalmologist in New York, New York. Dr. Kazim is rated as an Elite provider by MediFind in the treatment of Thyroid Eye Disease. His top areas of expertise are Thyroid Eye Disease, Graves Disease, Optic Glioma, Turbinectomy, and Endoscopy.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Thyroid Eye Disease
Elite in Thyroid Eye Disease
Mainz, RP, DE 

George Kahaly practices in Mainz, Germany. Mr. Kahaly is rated as an Elite expert by MediFind in the treatment of Thyroid Eye Disease. His top areas of expertise are Graves Disease, Hyperthyroidism, Thyroid Eye Disease, Autoimmune Polyglandular Syndrome Type 2, and Thyroidectomy.

What are the latest Thyroid Eye Disease Clinical Trials?
Interventional, Open-label, Single-group, Long-term Follow-up Trial of Lu AG22515 in Patients With Moderate-to-severe Thyroid Eye Disease

Summary: This trial will evaluate the effects of Lu AG22515 in adult men and women with moderate-to-severe thyroid eye disease (TED). TED is an autoimmune condition closely related to Graves' Disease. In people with TED, the healthy tissue behind and around the eye becomes inflamed and swollen. One of the key symptoms of TED is proptosis (bulging eyes). The main goal of this trial is to learn whether treat...

Match to trials
Find the right clinical trials for you in under a minute
Get started
A Phase 3, Randomized, Double-Masked, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Efgartigimod PH20 SC Administered by Prefilled Syringe in Adult Participants With Thyroid Eye Disease

Summary: This study aims to evaluate the efficacy, safety and tolerability, pharmacokinetics (PK), pharmacodynamics (PD), and immunogenicity of efgartigimod PH20 SC in participants with active, moderate-to-severe TED, compared with placebo PH20 SC. After the screening period, eligible participants will be randomized in a 2:1 ratio to receive efgartigimod PH20 SC or placebo PH20 SC, respectively during the ...